Equity Profile

COR

Cencora, Inc.

Health CareHealth Care Distributors$59.2B

Feb3Thu

Pre-Earnings Brief

UpcomingQ3-2026Pre-Market9:00 AM EST

Company Snapshot

Cencora, Inc. is a major player in the health care sector, focusing on distributing pharmaceuticals and health care products....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of a company's profitability and will show how well Cencora is managing its costs and generating profits.

N/A

Revenue Growth

Revenue growth is essential to assess how well Cencora is expanding its market presence and meeting customer demand.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

COR Q3-2026 Earnings Preview

Context

Company Snapshot

Cencora, Inc. is a major player in the health care sector, focusing on distributing pharmaceuticals and health care products. With a market cap of $59 billion, the company plays a crucial role in ensuring that health care providers have the necessary supplies to serve patients effectively.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+3.76%

Avg Stock Reaction

-1.64%

Last Quarter Recap

In the last quarter, Cencora reported an EPS of $4.75, slightly missing the estimate of $4.80. Following the announcement, the stock experienced a significant drop of 17.38% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautious ahead of Cencora's earnings report, especially after the recent earnings miss. The market is looking for signs of recovery in profitability and revenue growth.

Bull Case

If Cencora can exceed EPS expectations and show strong revenue growth, it could signal a turnaround, boosting investor confidence and stock price.

Bear Case

Conversely, if the company reports another earnings miss or weak revenue growth, it could lead to further declines in stock price, especially given the recent negative trends.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q3-2026?

Given the recent earnings miss, the market will be closely watching EPS to gauge whether the company is on a recovery path.

What is the outlook for revenue growth in the upcoming quarter?

Revenue growth is critical for Cencora's long-term success, and any guidance on this will significantly impact investor sentiment.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Cencora's ability to rebound from recent earnings misses, especially if they can demonstrate improved operational efficiency.

Supporting Evidence

Cencora has a history of beating EPS estimates 88% of the time, suggesting potential for a surprise.

The options market is pricing a move of only 0.94%, indicating low expectations that could lead to a larger reaction if results exceed those expectations.

Key Risk

If the EPS comes in above $4.85, it could significantly shift market sentiment in favor of the bulls.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the potential for recovery against the backdrop of recent earnings misses, making this quarter pivotal for Cencora.

Bull Confirmed If

An EPS of $4.85 or higher would confirm the bull case and indicate a positive trend.

Bear Confirmed If

An EPS below $4.60 would confirm the bear case and raise concerns about the company's profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±0.94%

Historical Avg

±5.6%

Pricing cheap

The options market is pricing a relatively small move, indicating that traders expect limited volatility around the earnings announcement.

Options are pricing ±0.9% while COR has averaged ±5.6% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.3%

30d HV

60.2%

Calls (13K)P/C Ratio: 0.19Puts (105K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cencora beats expectations, history suggests the stock could rise by around 0.61%, confirming a positive trend.

In-Line / Cautious

If results are in line with expectations, the stock may see a muted reaction as investors await further clarity from management.

Miss

A miss could lead to a significant drop, potentially around 17.38%, as seen in previous quarters.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies that could improve margins.
2Details on new contracts or partnerships that may drive revenue growth.
3Management's commentary on market conditions and competitive landscape.
4Insights into inventory management and supply chain efficiency.
5Guidance on future earnings expectations and strategic initiatives.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Cirrus Logic, Inc.

Company Snapshot

Cencora, Inc. is a major player in the health care sector, focusing on distributing pharmaceuticals and health care products....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of a company's profitability and will show how well Cencora is managing its costs and generating profits.

N/A

Revenue Growth

Revenue growth is essential to assess how well Cencora is expanding its market presence and meeting customer demand.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

COR Q3-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+3.76%

Avg Stock Reaction

-1.64%

Last Quarter Recap

In the last quarter, Cencora reported an EPS of $4.75, slightly missing the estimate of $4.80. Following the announcement, the stock experienced a significant drop of 17.38% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautious ahead of Cencora's earnings report, especially after the recent earnings miss. The market is looking for signs of recovery in profitability and revenue growth.

Bull Case

If Cencora can exceed EPS expectations and show strong revenue growth, it could signal a turnaround, boosting investor confidence and stock price.

Bear Case

Conversely, if the company reports another earnings miss or weak revenue growth, it could lead to further declines in stock price, especially given the recent negative trends.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q3-2026?

Given the recent earnings miss, the market will be closely watching EPS to gauge whether the company is on a recovery path.

What is the outlook for revenue growth in the upcoming quarter?

Revenue growth is critical for Cencora's long-term success, and any guidance on this will significantly impact investor sentiment.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Cencora's ability to rebound from recent earnings misses, especially if they can demonstrate improved operational efficiency.

Supporting Evidence

Cencora has a history of beating EPS estimates 88% of the time, suggesting potential for a surprise.

The options market is pricing a move of only 0.94%, indicating low expectations that could lead to a larger reaction if results exceed those expectations.

Key Risk

If the EPS comes in above $4.85, it could significantly shift market sentiment in favor of the bulls.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the potential for recovery against the backdrop of recent earnings misses, making this quarter pivotal for Cencora.

Bull Confirmed If

An EPS of $4.85 or higher would confirm the bull case and indicate a positive trend.

Bear Confirmed If

An EPS below $4.60 would confirm the bear case and raise concerns about the company's profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±0.94%

Historical Avg

±5.6%

Pricing cheap

The options market is pricing a relatively small move, indicating that traders expect limited volatility around the earnings announcement.

Options are pricing ±0.9% while COR has averaged ±5.6% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.3%

30d HV

60.2%

Calls (13K)P/C Ratio: 0.19Puts (105K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cencora beats expectations, history suggests the stock could rise by around 0.61%, confirming a positive trend.

In-Line / Cautious

If results are in line with expectations, the stock may see a muted reaction as investors await further clarity from management.

Miss

A miss could lead to a significant drop, potentially around 17.38%, as seen in previous quarters.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies that could improve margins.
2Details on new contracts or partnerships that may drive revenue growth.
3Management's commentary on market conditions and competitive landscape.
4Insights into inventory management and supply chain efficiency.
5Guidance on future earnings expectations and strategic initiatives.